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Recent progress has been achieved in our understanding
of the molecular mechanisms responsible for the sporadic
character of EPP-associated liver disease. For instance, a
recent study has shown that ‘‘patients with EPP who develop
liver disease usually have a mutation in one ferrochelatase
allele that alters enzyme function, together with a polymorph-
ism in the nonmutant allele that causes low gene expression’’
(Bloomer et al, 2005). This observation makes it unlikely that
the rare cases of recurrence of disease in a donor liver after
transplantation for protoporphyric liver failure occur in per-
fectly normal donor livers, and relapse may be caused by the
existence of a heterozygosity for a defective ferrochelatase
allele within the donor organ. This molecular lesion may re-
main clinically silent in the donor individual until the liver is
transplanted into a recipient with excess protoporphyric pro-
duction from the bone marrow compartment. Alternatively,
another molecularly unrelated pathological process may pre-
exist in the donor organ, thereby co-contributing to the es-
tablishment of liver disease. Studies in EPP mouse models of
various genetic backgrounds, although bearers of the same
ferrochelatase genetic mutation, have pointed to the major
role played by modifier genes on the occurrence and the
severity of associated liver disease (Abitbol et al, 2005). Al-
though these hypotheses remain to be documented, the
aforementioned observations do not directly support the
contention that restoring or enhancing local ferrochelatase
activity in a target organ will be ineffective at protecting it
from toxicity triggered by systemic excess in protoporphyrin.
It is also relevant to note that specific alterations of iron
metabolism, as in the targeted deletion of iron regulatory
protein 2, display a complex phenotype that, in part, mimics
EPP, with markedly increased levels of free protoporphyrin
IX, zinc-protoporphyrin, and skin photosensitivity (Cooper-
man et al, 2005). Interestingly, the rare cases of acquired,
late-onset EPP, cited by Elder are triggered by complex or
compounded genetic defects that include abnormalities of
iron metabolism such as sideroblastic anemia (Lim et al,
1992). In these genetically heterogeneous cases, it is thus
possible that enhanced or associated pathological proc-
esses may alter the clinical expression of the disease and/or
may be too pronounced to be surmounted by normal skin
ferrochelatase activity. Interestingly, the adult-onset EPP
patients seem to have higher protoporphyrin levels (11.9
and 112 mmol per liter in Aplin et al, 2001 and Goodwin et al,
2002, respectively) than many patients with the usual child-
hood-onset EPP (10 of 32 patients had less than 10 mmol
per liter in DeLeo et al, 1976). Even in cases of major serum
protoporphyrin elevation, it nevertheless remains possible
that cutaneous gene therapy would result in greater local
ferrochelatase activity than normal and would reach suffi-
cient levels to become effective for dermal protection.
Thus, the clinical examples reviewed by Elder may stim-
ulate further experimentation and discussion but do not per
se support his contention that symptomatic relief cannot be
obtained in certain patients with congenital EPP by eliciting
high levels of dermal ferrochelatase activity through local
gene transfer. The ideal way to treat EPP is to replace or
correct the defective ferrochelatase gene in hematopoietic
stem cells, either by gene therapy targeting the marrow
(Pawliuk et al, 1999) or by allogenic bone marrow trans-
plantation (Poh-Fitzpatrick et al, 2002). But these two meth-
ods involve significant risk at the present time, and thus
cannot be widely used in this relatively benign disorder. If
safe and effective gene transfer to the skin can be achieved,
relief may be obtained in a sub-population of EPP patients.
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Transglutaminase 5 Expression in Human Hair Follicle
To the Editor:
Transglutaminases (TG) are Ca2þ -dependent enzymes
catalyzing the formation of isodipeptide cross-links
among protein-bound lysines and glutamines, generat-
ing insoluble macromolecular aggregates (Greenberg
et al, 1991; Reichert et al, 1993; Steven and Steinert,
1994; Nemes and Steinert, 1999). TG are involved in
epidermal terminal differentiation (Rice and Green,
1977; Michel et al, 1992; Eckert et al, 1993; Candi et al,
1995).
Abbreviations: IRS, inner root sheath; ORS, outer root sheath; TG,
transglutaminases
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Figure 1
Distribution of involucrin and transglutaminase (TG)1, -5, and -3 in human hair follicle. Distribution of involucrin, transglutaminase (TG)1, -5,
and -3 expressing cells in the infundibulum (A, D, G, J), distal part (B, E, H, K), and proximal part of terminal anagen hair follicle (C, F, I, L).
Longitudinal cryo-sections were reacted with Sy5 and B.C1 monoclonal antibodies (1:40 and 1:20, respectively) or anti-TG5 (Candi et al, 2002) and
anti-TG3 (Tarcsa et al, 1997) polyclonal antibodies (1:200), then revealed by streptavidin–peroxidase complex. Note that TG5, as involucrin, was
expressed in inner root sheath (IRS) and hair shaft (C, I), whereas TG1 was restricted to the three layers of IRS (F). In the distal part, the distribution of
these three proteins extended to outer root sheath (ORS) (B, E, H). In the epidermis, TG1 (D) was restricted to granular layer, whereas involucrin
decorated stratum granulosum and corneum (A) and TG5 was expressed in the whole epidermis (G). TG3 was detected in the hair shaft and the hair
cuticle of the lower part (L), absent of the ORS (K), and expressed in the epidermal upper granular layers (J). Scale bar: 50 mm. The medical ethical
committee of the IDI-IRCCS approved all described studies. The study was conducted according to Declaration of Helsinki Principles.
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In the human hair follicle, cornified cell envelope (CCE)
formation occurs in the hair shaft, hair cuticle, outer root
sheath (ORS), and in the isthmus region (Akiyama et al,
1999). TG and the major CCE precursor proteins (involucrin,
loricrin, SPR-1 and -2) are coordinately expressed in de-
veloping human hair follicle (Akiyama et al, 2002). Involucrin
and loricrin are expressed in the hair canal, inner root sheath
(IRS) and ORS of the bulbous hair peg and the differentiated
lanugo hair follicle (Tamada et al, 1995; Akiyama et al, 1999).
TG1 is present in the three IRS layers, both in the bulbar and
suprabulbar portions of human anagen (Commo and Bern-
ard, 1997; Yoneda et al, 1998). TG2 is present in the hair
germ, as the first active TG, and in the IRS of terminal ana-
gen follicles (Akiyama et al, 2002). Although TG3 is detected
in the mouse IRS and hair medulla, and absent from the hair
cortex, its expression pattern in human hair follicle is un-
clear. The more recently identified epidermal TG5 (Hashi-
moto, 1988; Candi et al, 2001, 2002; Rufini et al, 2004) has
not been studied in human hair follicle.
Here, using a specific anti-TG5 antibody, we compared
the expressions pattern of TG and involucrin in human adult
anagen hair follicle.
As described (Candi et al, 2002), TG3 was restricted to
upper granular layers (Fig 1J), and TG5 expression followed
a gradient of concentration from the basal to the most dif-
ferentiated layers (Fig 1G). Involucrin and TG1 decorated
the stratum granulosum (Fig 1A,D). In the human anagen,
involucrin decorated the three layers of IRS (cuticle,
Huxley’s layer, and Henle’s layer). In the lower part, a weak
staining was also detected in the hair cuticle and the hair
shaft (Fig 1C). In the distal part, this distribution extended to
the innermost layer of ORS (Fig 1B). TG1 expression was
restricted to the IRS cells (Fig 1F) and the innermost layer of
ORS in the distal part (Fig 1E). TG5 distribution in the prox-
imal part of the follicle was similar to involucrin. All three IRS
layers strongly expressed TG5, and a weak staining was
also detected in the hair cuticle and hair shaft (Fig 1H–I).
Conversely, TG3 was absent from IRS and ORS layers all
along the follicle (Fig 1K). TG3 expression thus seemed
to be restricted and specific of the hair shaft and the hair
cuticle (Fig 1L).
TG5 and its substrate, involucrin, revealed a very close
distribution. Although both patterns became distinct in the
distal part of the ORS, they were identical in the proximal
part of the hair follicle (see Fig 1A–C,G–I).Table I summa-
rizes anagen hair follicle TG and involucrin staining.
Refined confocal colocalization of TG and involucrins in
transverse and longitudinal sections (Fig 2A,C) confirmed
the different staining of TG, with TG5 overlapping with
involucrin (Fig 2A–C). Their distribution in the IRS, along
the follicle longitudinal axis, was visualized in transverse
sections. Fig 2D–E showed that the double staining was
present, first, in Henle’s layer, then in the three layers,
and as IRS progressively matured, TG5 labelling became
restricted to Huxley’s layer. These proteins were perfectly
coexpressed in the hair bulb (Fig 2H). Deconvolution anal-
ysis to separate green (involucrin) and red (TG5) channels
showed a diagonal distribution (Fig 2F–G), indicating a
super-imposable distribution patterns. White-colored cells
(expressing both proteins with maximal intensities) deco-
rated IRS layers and hair shaft (Fig 2H). These results sug-
gested that TG5, together with involucrin, could play an
important role during all the hair IRS keratinization process.
TG5 and -3 have a strikingly different expression pattern
(Fig 2I–P,Q–S), with TG3 mainly expressed in the hair shaft.
TG3 did not codistribute with involucrin (Fig 2I–K). Trans-
verse sections in proximal and medium sections of the hair
follicle showed that the TG distribution was restricted to hair
cuticle and cortex (Fig 2L,M, L–Q). Intensities of both chan-
nels were analyzed and two distinct populations of spots
were distributed along each axis. Only very few spots were
found in the region where both intensities were maximal.
These spots (white colored) revealed that only very few
cortical cells coexpressed TG3 and involucrin (Fig 2P).
Hence, both proteins were exclusive from each other.
In conclusion, TG5 is expressed during hair follicle home-
ostasis. TG1 and -5 may cooperate in human hair follicle, and
their distribution in the complete pilo-sebaceous unit suggest
that they probably play a complementary and sequential role
in the hair CCE formation. By homology with epidermis, TG5
could also have a function in hair follicle homeostasis.
TG3 revealed a strikingly different distribution in com-
parison with TG5. TG3 was specifically expressed in the
cortex and the cuticle of terminal hair follicles. During the
CCE formation in fetal hair follicle, TG3 and -1 are ex-
pressed during the bulbous hair peg in the hair canal and
IRS (Tamada et al, 1995; Akiyama et al, 2002). This pattern is
maintained in differentiated lanugo hair follicle, although this
was not fully supported by our results. This discrepancy
might be related to the developmental stage studied, name-
ly fetal versus adult hair.
Conversely, TG3 revealed a different distribution in the
mouse anagen hair (Lee et al, 1993). TG3 expression oc-
curred in the IRS and ORS, and also in the medulla sparing
the cortex, as did the structural protein trichohyalin (THH).
TG3 is required for THH cross-linking (Lee et al, 1993;
Langbein et al, 2003). Thus, THH would confer to TG3 a
Table I. Distribution of TGase1, 5, 3, and involucrin in human
hair follicle
Involucrin TGase1 TGase5 TGase3
ORS—distal
External layer   þ 
Internal layer þ þ þ 
ORS—proximal
External layer    
Internal layer    
IRS—distal
Henle þ þ þ 
Huxley þ þ þ 
Cuticle þ þ þ 
Shaft
Cuticle þ /  þ / þ
Cortes þ /  þ / þ
ORS, outer root sheath; IRS, inner root sheath.
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function in the keratinization of the developing hair, consid-
ering the major hair compartment represented by the me-
dulla in mouse hair. Although hair substrate and enzyme
distribution varies with species, our data indicate that TG5
and -3 could play a role in hair shaft differentiation and
building-up, and have a key function in the cross-linking of
this structure (Tarcsa et al, 1997). Considering the strong
specificity of ORS, IRS, and hair shaft differentiation pro-
grams as exemplified by their specific keratin subsets, one
might hypothesize that if TG1 and -5 may cooperate during
the IRS and ORS ways of differentiation, TG3 could play a
parallel role in the hair shaft differentiation.
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Figure2
Comparison by indirect immunofluorescence of ex-
pression patterns of transglutaminase (TG)5, -3, and
involucrin. TG5, revealed by cyanine 3 (red) (A), and in-
volucrin location, revealed by FITC (green) (B), were similar.
Longitudinal (C) and transversal (D, E) sections of anagen
hair follicle showed a co-location, in yellow, in inner root
sheath (IRS) and hair shaft. Laser confocal microscopy
analysis. Note that both distributions of channel intensities
(cyanine 3 and FITC) were super imposable and on the
same diagonal (G, F), which meant that both enzymes
were co-located. The selection of TG5 and involucrin ex-
pressing cells with high intensity (white spots, H) corre-
sponded to IRS and cortical cells. Contrary to involucrin
(green) (J), TG3 (red) (I) location was restricted to hair cu-
ticle and cortex. Longitudinal (K) and transverse sections
(L, M) showed two distinct patterns. Two distinct popula-
tions were distributed along each axis (N, O). The selection
of spots with high red and green intensities (N, O) revealed
that only very few cortical cells (white spots) co-expressed
TG3 and involucrin (P). Additional transversal sections are
shown (Q–S). The medical ethical committee of the IDI-
IRCCS approved all described studies. The study was
conducted according to Declaration of Helsinki Principles.
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